Antibodies News and Research RSS Feed - Antibodies News and Research

Antibody drug offers new therapeutic approach for treating AML

Antibody drug offers new therapeutic approach for treating AML

An antibody drug that targets a surface marker on cancer stem cells could offer a promising new therapeutic approach for treating acute myeloid leukemia (AML), a form of blood cancer that affects an estimated 50,000 people in Saudi Arabia. [More]
New Chromatrap ChIP-validated antibodies now available for mammalian epigenetic research

New Chromatrap ChIP-validated antibodies now available for mammalian epigenetic research

Chromatrap announces that seven further popular antibodies have been validated for use in chromatin immunoprecipitation (ChIP) assays by their UK-based research team. [More]
Mayo Clinic article provides better understanding on potentially devastating liver disease

Mayo Clinic article provides better understanding on potentially devastating liver disease

An article published today in the New England Journal of Medicine updates the medical community on a potentially devastating liver disease that afflicts approximately 29,000 Americans. [More]
Experimental drug may prevent development of multiple sclerosis in mice

Experimental drug may prevent development of multiple sclerosis in mice

The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology. [More]
Experts receive $5.2 million NIH grant to develop affordable test for diagnosing Chagas disease

Experts receive $5.2 million NIH grant to develop affordable test for diagnosing Chagas disease

An international team of researchers led by infectious disease experts at the University of Georgia has received $5.2 million from the National Institutes of Health to develop a more accurate, affordable diagnostic test for Chagas disease, a parasitic infection that kills more than 50,000 people each year in Central and South America. [More]
BBI Solutions introduces novel conjugate blocking technology to improve performance of lateral flow immunoassays

BBI Solutions introduces novel conjugate blocking technology to improve performance of lateral flow immunoassays

BBI Solutions has launched Morffi, a novel conjugate blocking technology that enhances signal intensity and improves the sensitivity of lateral flow immunoassays, at the Lateral Flow Test Development seminar in Seattle, USA, on the 20th September. [More]
First case-control study examines link between microcephaly and in utero Zika virus infection

First case-control study examines link between microcephaly and in utero Zika virus infection

The relation between Zika virus and microcephaly is widely assumed to be causal because of strong evidence of an association. However, evidence so far comes from case reports, case series, modelling studies, and preliminary reports from cohort studies – none of which have included appropriate control groups. [More]
AMSBIO creates new 24-page guide for researchers using heparan sulfate antibodies

AMSBIO creates new 24-page guide for researchers using heparan sulfate antibodies

AMSBIO has produced a new 24-page guide that brings together applications, protocols, results and citations to provide an informative resource for researchers using heparan sulfate antibodies. [More]
Guidelines for staying healthy during flu season

Guidelines for staying healthy during flu season

The American Academy of Pediatrics updated its annual influenza (flu) season guidelines, withdrawing the child-friendly nasal flu vaccine, FluMist, this year. [More]
Desalination can increase prevalence of inadequate iodine intake

Desalination can increase prevalence of inadequate iodine intake

Hebrew University study suggests that desalination can dramatically increase the prevalence of inadequate iodine intake. [More]
Food intolerance testing: an interview with Dr Gill Hart

Food intolerance testing: an interview with Dr Gill Hart

Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances. [More]
Study shows possibility to achieve immunological antibody memory with mucosal vaccination

Study shows possibility to achieve immunological antibody memory with mucosal vaccination

If a vaccine is to protect the intestines and other mucous membranes in the body, it also needs to be given through the mucosa, for example as a nasal spray or a liquid that is drunk. [More]
Discovery of immune antibody could lead to development of improved influenza vaccines

Discovery of immune antibody could lead to development of improved influenza vaccines

Dana-Farber Cancer Institute investigators report they have discovered a type of immune antibody that can rapidly evolve to neutralize a wide array of influenza virus strains - including those the body hasn't yet encountered. [More]
IRB Barcelona researchers reveal new strategy to obtain barrel-shaped amyloid-beta aggregates

IRB Barcelona researchers reveal new strategy to obtain barrel-shaped amyloid-beta aggregates

Researchers at IRB Barcelona describe for the first time how to prepare a specific type of aggregate of the amyloid-beta protein with the ability to perforate the cell membrane. [More]
Study shows holes in HIV's protective glycan shield could be vital in designing vaccine candidates

Study shows holes in HIV's protective glycan shield could be vital in designing vaccine candidates

A new study from scientists at The Scripps Research Institute shows that "holes" in HIV's defensive sugar shield could be important in designing an HIV vaccine. [More]
TSRI, IAVI scientists reveal new reductionist vaccine strategy to fight against HIV

TSRI, IAVI scientists reveal new reductionist vaccine strategy to fight against HIV

A series of new studies led by scientists at The Scripps Research Institute and the International AIDS Vaccine Initiative describe a potential vaccination strategy to jump-start the selection and evolution of broadly effective antibodies to prevent HIV infection. [More]
Gut microbiota may play role in influencing food allergies

Gut microbiota may play role in influencing food allergies

Countless microorganisms live in the intestinal tract. Researchers at the Technical University of Munich (TUM) have been able to demonstrate that intestinal bacteria also play a role in determining the strength of anaphylactic reactions to food allergens. [More]
CHORI scientists reveal improved protective antibody responses to new meningococcal vaccine

CHORI scientists reveal improved protective antibody responses to new meningococcal vaccine

A study conducted by UCSF Benioff Children's Hospital Oakland Research Institute scientists shows greatly improved protective antibody responses to a new mutant vaccine antigen for prevention of disease caused by Neisseria meningitidis - also known as meningococcus - that has the potential to improve the current vaccines for meningitis. [More]
New biomarker test helps detect autoimmune-induced neuropsychiatric disorders

New biomarker test helps detect autoimmune-induced neuropsychiatric disorders

A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health, has developed the first-of-its-kind biomarker test to help detect autoimmune-induced neuropsychiatric disorders. [More]
Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

In research published online today in Science, a team of scientists describe a new therapeutic strategy to target a hidden Achilles' heel shared by all known types of Ebola virus. [More]
Advertisement
Advertisement